Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $2.8 million.

  • Myriad Genetics' Other Working Capital Changes rose 1200.0% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 6333.33%. This contributed to the annual value of $3.7 million for FY2024, which is 1590.91% down from last year.
  • Per Myriad Genetics' latest filing, its Other Working Capital Changes stood at $2.8 million for Q3 2025, which was up 1200.0% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Other Working Capital Changes registered a high of $6.6 million during Q4 2022, and its lowest value of -$11.7 million during Q2 2021.
  • In the last 5 years, Myriad Genetics' Other Working Capital Changes had a median value of $450000.0 in 2022 and averaged -$761111.1.
  • Examining YoY changes over the last 5 years, Myriad Genetics' Other Working Capital Changes showed a top increase of 115000.0% in 2021 and a maximum decrease of 176666.67% in 2021.
  • Quarter analysis of 5 years shows Myriad Genetics' Other Working Capital Changes stood at -$6.2 million in 2021, then skyrocketed by 206.45% to $6.6 million in 2022, then plummeted by 78.79% to $1.4 million in 2023, then plummeted by 164.29% to -$900000.0 in 2024, then skyrocketed by 411.11% to $2.8 million in 2025.
  • Its Other Working Capital Changes was $2.8 million in Q3 2025, compared to -$1.9 million in Q2 2025 and $2.2 million in Q1 2025.